Islet regeneration during the reversal of autoimmune diabetes in NOD mice

S Kodama, W Kuhtreiber, S Fujimura, EA Dale… - Science, 2003 - science.org
S Kodama, W Kuhtreiber, S Fujimura, EA Dale, DL Faustman
Science, 2003science.org
Nonobese diabetic (NOD) mice are a model for type 1 diabetes in humans. Treatment of
NOD mice with end-stage disease by injection of donor splenocytes and complete Freund's
adjuvant eliminates autoimmunity and permanently restores normoglycemia. The return of
endogenous insulin secretion is accompanied by the reappearance of pancreatic β cells.
We now show that live donor male or labeled splenocytes administered to diabetic NOD
females contain cells that rapidly differentiate into islet and ductal epithelial cells within the …
Nonobese diabetic (NOD) mice are a model for type 1 diabetes in humans. Treatment of NOD mice with end-stage disease by injection of donor splenocytes and complete Freund's adjuvant eliminates autoimmunity and permanently restores normoglycemia. The return of endogenous insulin secretion is accompanied by the reappearance of pancreatic β cells. We now show that live donor male or labeled splenocytes administered to diabetic NOD females contain cells that rapidly differentiate into islet and ductal epithelial cells within the pancreas. Treatment with irradiated splenocytes is also followed by islet regeneration, but at a slower rate. The islets generated in both instances are persistent, functional, and apparent in all NOD hosts with permanent disease reversal.
AAAS